Medical University of Vienna
Vienna, 1090, Austria
NCT Number: NCT04841759
The SARS-CoV2 pandemic has kept the world in suspense for over a year now. Almost 100 million people around the world have contracted COVID-19 to date and over 2 million people have died of COVID-19 by the end of January 2021.
Despite the tragedy of these deaths, it must be pointed out at this point that the number of COVID-19 survivors is significantly larger. These COVID-19 survivors are now the focus of interest in rehabilitation measures, as it has been shown that survival of the disease does not go hand in hand with a complete cure. Thirty-five percent of all COVID-19 survivors and 87% of the COVID-19 survivors who were hospitalized in the course of their illness suffer from after-effects that are currently summarized as post-COVID fatigue syndrome also known as "Long-COVID".
As health care workers are at higher risk of contracting SARS CoV2 and furthermore, considering their central role in the overcoming of this pandemic, a COVID-19 rehabilitation program for healthcare workers of the Medical University of Vienna, Austria as well as the General Hospital of Vienna, Austria - together the second-largest university-clinic in the world - was developed as part of workplace health promotion. Nowadays, the fatigue syndrome is primarily known as a side effect of cancer treatment and thus from the rehabilitation of cancer patients. Cancer-related fatigue is a massive limiting side effect for patients and the currently most effective treatment strategy against cancer-associated fatigue syndrome is physical training.
The idea for this current project is, that physical exercise might have similar effects on post-SARS-CoV2 fatigue as it has on cancer-related fatigue.
The current study evaluates the effects of this primarily exercise-based rehabilitation program on Long-COVID fatigue.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Vienna, 1090, Austria
Employees of the Medical University of Vienna, Austria and the General Hospital of Vienna, Austria who survived a SARS-CoV2 infection will be invited to take part in an eight weeks post-COVID-19 rehabilitation program which is part of a workplace health promotion measure. This program consists of eight weeks of exercising (twice per week supervised resistance training + individual, heart-rate controlled endurance training recommendations) with a sports scientist and a sports medicine specialist, complemented by one session of nutrition consultation with a nutritionist and two sessions of psychological consultation with a clinical psychologist.
Parallel to this workplace health promotion program, the scientific evaluation of this intevention will be undertaken via this study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
8 week exercise program, nutritional & psychological consultation
Time frame: Baseline, 4 weeks, 8 weeks
Measurement of VO2max during an exhaustive CPET is the gold standard for objectifying cardiopulmonary performance and detecting any cardiovascular risks under stress. VO2max will be measured in ml/kg bodyweight.This examination is the gold standard for objectifying cardiopulmonary performance and detecting any cardiovascular risks under stress.
Time frame: Baseline, 4 weeks, 8 weeks
The 6MWT is used, among other things, to assess and control cardiovascular and pulmonary performance below the anaerobic threshold. This test is used for the clinical evaluation of the basic motor property endurance and measures the distance a patient can walk as quickly as possible on a flat, hard surface in a period of 6 minutes. It will be measured in meters.
Time frame: Baseline, 4 weeks, 8 weeks
The 30seconds Sit-to-Stand test is a well-established functional test used to estimate the strength endurance of the lower extremities and describes how often the test person can get up from a chair and sit down again in a period of 30 seconds. In patients suffering from chronic obstructive pulmonary disease (COPD), the 30seconds sit-to-stand test has proven to be a valid and reliable parameter.
Time frame: Baseline, 4 weeks, 8 weeks
BiA is a non-invasive method for measuring body composition and serves as a basis for assessing metabolic disease risks among others by measuring body fat in absolute (kg) numbers.
Time frame: Baseline, 4 weeks, 8 weeks
BiA is a non-invasive method for measuring body composition and serves as a basis for assessing metabolic disease risks among others by measuring body fat in relative (%) numbers.
Time frame: Baseline, 4 weeks, 8 weeks
BiA is a non-invasive method for measuring body composition and serves as a basis for assessing metabolic disease risks among others by measuring lean body mass in absolute (kg) numbers.
Time frame: Baseline, 4 weeks, 8 weeks
BiA is a non-invasive method for measuring body composition and serves as a basis for assessing metabolic disease risks among others by measuring lean body mass in relative (%) numbers.
Time frame: Baseline, 4 weeks, 8 weeks
The GAD-7 (Generalized Anxiety Disorder 7) is a module of the health questionnaire for patients (PHQ-D), which was designed to identify patients with generalized anxiety disorder and to record the severity of symptoms of generalized anxiety (7 items). Scores range from 0 to 21 points with low scores representing low general anxiety and high scores representing high general anxiety.
Time frame: Baseline, 4 weeks, 8 weeks
The questionnaire PHQ-9 corresponds to the depression module of the health questionnaire for patients (PHQ-D). It was developed as a screening instrument for the diagnosis of depression for routine use in the somatic medical field (9 items). Scores range from 0 to 27 points with low scores representing low levels of depression and high scores representing high levels of depression.
Time frame: Baseline, 4 weeks, 8 weeks
The PSS-10 measures the subjective experience of stress. It records the dimensions of self-efficacy and helplessness in two scales, as well as an overall stress score (10 items). Scores range from 0 to 50 points with low scores representing low stress levels and high scores representing high stress levels.
Time frame: Baseline, 4 weeks, 8 weeks
The BFI measures the severity and extent of fatigue. The questionnaire covers six dimensions: activity, mood, ability to walk, work, relationship with other people and joie de vivre (10 items). Scores range from 0 to 10 points with low scores representing low fatigue and high scores representing high fatigue.
Time frame: Baseline, 4 weeks, 8 weeks
The Brief Resilience Scale measures resilience, the ability to successfully cope with difficult, stressful situations or to recover quickly from them (6 items). Scores range from 1 to 5 points with low scores representing low resilience and high scores representing high resilience.
Time frame: Baseline, and before every supervised resistance exercise session
Data on the fist force in kg (measurement of the basic motor property force), which are collected using a JAMAR® dynamometer.
Time frame: Baseline, and before every supervised resistance exercise session
The Post-COVID-19 Functional Scale is a questionnaire for self-assessment of physical and functional limitations after a COVID-19 infection. It ranges from 0 (no functional impairment) to 4 (severe functional impairments).
Time frame: Baseline, 4 weeks, 8 weeks
The Work Ability Index (WAI) is a measuring instrument for recording the work ability of employees. The WAI is a questionnaire that is filled out either by the respondents themselves or by third parties, e.g. company doctors during the company medical examination. The WAI is predictive of reintegration into working life after workplace-specific rehabilitation against back pain. WAI scores range from 7-27 (poor), over 28-36 (moderate), and 37 to 43 (good) to 44-49 (very good).
Time frame: Baseline, 4 weeks, 8 weeks
TnT (0 - 14 ng/L) is a heart-specific and very sensitive marker for myocardial damage in case of elevated values
Time frame: Baseline, 4 weeks, 8 weeks
BNP (0 - 125 pg/ml) is increased in cardiac insufficiency and increased volume load on the heart
Time frame: Baseline, 4 weeks, 8 weeks
CK-MB (< 24 U/l) are elevated in cardiac muscle diseases e.g. myocardial infarction, myocarditis, ischemic conditions e.g. angina pectoris, or for the differential diagnosis of muscle diseases
Time frame: Baseline, 4 weeks, 8 weeks
CRP (< 0,5 mg/dl) is an "acute phase protein" which increases in infections (bacterial, less viral and fungi), inflammation, post-OP, malignant processes; ultra-sensitive CRP is additionally a risk assessment marker of aterosclerosis
Time frame: Baseline, 4 weeks, 8 weeks
IL-6 (<= 7 pg/mL) is a mediator of the immune system and elevated in inflammatory processes
Time frame: Baseline, 4 weeks, 8 weeks
Cholesterol (< 200 mg/dL) is a risk factor for early atherosclerosis
Time frame: Baseline, 4 weeks, 8 weeks
Triglycerides (< 150 mg/dl) increased in primary hyperlipidemia as a risk faktor for cardiovascular diseases
Time frame: From the first exercise session over 8 weeks until the last exercise session (daily)
Spare time physical activity is a key indicator for physical function and will be measured via activity tracker
Time frame: From the first exercise session over 8 weeks until the last exercise session (daily)
Spare time physical activity is a key indicator for physical function and will be measured via activity tracker
Time frame: From the first exercise session over 8 weeks until the last exercise session (daily)
Spare time physical activity is a key indicator for physical function and will be measured via activity tracker
Time frame: From the first exercise session over 8 weeks until the last exercise session (daily)
A low average heart rate during activities of daily living is an indicator for a relatively low cardiovascular load
Time frame: From the first exercise session over 8 weeks until the last exercise session (daily)
A low maximum heart rate during activities of daily living is an indicator for a relatively lower level of cardiovascular load
Time frame: From the first exercise session over 8 weeks until the last exercise session (daily)
A high oxygen saturation is an indicator for a well functioning gas exchange in the lungs and distribution into the circulatory system
Time frame: Baseline, 8 weeks
The MoCA test is a screening instrument for Mild Cognitive Impairment. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation.
Time frame: Baseline, 4 weeks, 8 weeks
The Insomnia Severity Index (ISI) is a brief self-report instrument measuring the patient's perception of both nocturnal and diurnal symptoms of insomnia.
Time frame: Baseline only
Carboxy-terminal type I collagen (CTX-1; 0.003-0.44 ng/ml) is a marker of bone resorption.
Time frame: Baseline only
Procollagen type 1 amino-terminal propeptide (P1NP; 20-92 ng/ml) is an early marker of bone formation.
Time frame: Baseline only
Bone-specific alkaline phosphatase (BAP) is used to detect minor changes in bone turnover.
Time frame: Baseline only
Osteocalcin (Oc; 11-46 ng/ml) is a late marker of bone formation.
Time frame: Baseline only
25-OH-vitamin D (75-250 nmol/l) is the precursor for calcitriol, the active form of vitamin D which is essential for calcium metabolism
Time frame: Baseline only
Parathyroid hormone (PTH; 15-65 pg/ml) regulates the serum calcium concentration through its effects on bone, kidney, and intestine.
Medical University of Vienna
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05204511
Behavior, COVID-19
Vienna, Austria
View Trial DetailsNCT07722000
COVID-19, Chronic Disease
Banī Suwayf, Beni Suweif Governorate, Egypt
View Trial DetailsNCT05876377
COVID-19, Chronic Disease
New York, United States
View Trial DetailsNCT05920616
COVID Long-Haul, COVID-19
Baltimore, Maryland, United States
View Trial Details